Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
170.55
-2.19 (-1.27%)
At close: Apr 28, 2026
107.66%
Market Cap 3.88B
Revenue (ttm) 1.68B
Net Income (ttm) 518.98M
Shares Out 22.75M
EPS (ttm) 22.81
PE Ratio 7.48
Forward PE n/a
Dividend 13.19 (7.63%)
Ex-Dividend Date Oct 27, 2025
Volume 501,988
Average Volume 398,175
Open 172.74
Previous Close 172.74
Day's Range 170.03 - 174.00
52-Week Range 67.02 - 232.95
Beta -0.03
RSI 58.61
Earnings Date May 25, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, central nervous system, dermatological, cardiovascular diseases, vitamins and minerals, analgesics and antipyretics, respiratory system, and gastrointestinal and metabolic disorders. It also provides products for anthelmintic, anti-hypertensi... [Read more]

Industry Pharmaceutical Preparations
Founded 1940
Employees 144
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MPCI
Full Company Profile

Financial Performance

In fiscal year 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.

Financial Statements

News

There is no news available yet.